Recent News for ODT - Odonate Therapeutics, Inc.

Date Title
Nov 9 Consolidated Research: 2018 Summary Expectations for Senior Housing Properties Trust, NACCO Industries, Primo Water, Martin Marietta Materials, Iamgold, and Odonate Therapeutics — Fundamental Analysis, Key Performance Indications
Nov 6 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $148,700 of Shares
Nov 5 74 Biggest Movers From Friday
Oct 30 Odonate Therapeutics: Insiders Buying This Oncology Concern
Oct 30 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $153,320 of Shares
Oct 26 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $610,393 of Shares
Oct 23 The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares
Oct 23 Odonate Therapeutics misses by $0.02
Oct 23 Odonate Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018
Oct 17 Report: Exploring Fundamental Drivers Behind Infinity Pharmaceuticals, AxoGen, MUELLER WATER PRODUCTS, MYR Group, RealNetworks, and Odonate Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
Oct 1 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $766,400 of Shares
Sep 27 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $790,000 of Shares
Aug 27 Weekly CEO Buys Highlight
Aug 24 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $146,122 of Shares
Aug 21 Odonate Therapeutics Inc (ODT) CEO Kevin C Tang Bought $968,361 of Shares
Aug 20 Report: Exploring Fundamental Drivers Behind Ballard Power, Reading International, Odonate Therapeutics, Stitch Fix, Summit Therapeutics, and Cellectis S.A — New Horizons, Emerging Trends, and Upcoming Developments
Jul 30 Odonate Therapeutics beats by $0.07
Jul 30 Odonate Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2018
Jun 8 Play the Best Sector of Summer With These ETFs & Stocks
Jun 6 Can The Uptrend Continue for Odonate Therapeutics (ODT)?
Jun 5 New Research: Key Drivers of Growth for Helen of Troy, Macro Bank, American Software, Shire plc, KB Financial Group, and Odonate Therapeutics — Factors of Influence, Major Initiatives and Sustained Production
Jun 4 The Week Ahead: Apple's Developer Conference In The Spotlight, ASCO Meeting Could Move Biotechs
Jun 2 Tesetaxel, Administered Orally as a Single Agent, Results in 45% Confirmed Response Rate in Patients with HER2 Negative, Hormone Receptor Positive, Metastatic Breast Cancer
Jun 2 Stocks To Watch: Eyes On Apple's WWDC, SCOTUS And D.C.
May 31 Odonate Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference

Back to the Main ODT Page...